1 Cardiology, Dallas Veterans Affairs Medical Center, Dallas, TX, USA.
2 Cardiology, UT Southwestern Medical Center, Dallas, TX, USA.
J Endovasc Ther. 2019 Apr;26(2):231-237. doi: 10.1177/1526602819829901. Epub 2019 Feb 11.
To investigate the effect of abdominal aortic aneurysm (AAA) size on mid- and long-term survival after endovascular aneurysm repair (EVAR).
Retrospective data were collected from 325 consecutive patients (mean age 69.7 ± 8.5 years; 323 men) who underwent EVAR for intact AAA at a single institution between January 2003 and December 2013. The primary endpoint was death at 3, 5, and 10 years after EVAR. Optimal cutoff points for AAA size and age were determined using receiver operating characteristics (ROC) curves. Time to event analyses (Kaplan-Meier curves and Cox proportional hazard models) were employed to determine any differences in all-cause mortality outcomes between AAA size groups. Cox models were adjusted for age and other comorbidities (hypertension, hyperlipidemia, coronary artery disease, smoking status, symptomatic status, and creatinine); the outcomes are reported as the hazard ratio (HR) with 95% confidence interval (CI).
The cohort was dichotomized according to the ROC analysis, which defined an optimal cutoff point of 5.6 cm for AAA size and >70 years for age. The mean follow-up period post EVAR was 45.5±29.2 months. In total, 134 (41.2%) patients died during the 10-year follow-up. Thirty-day mortality was 1.1% (2/184) in the patients with AAA <5.6 cm and 2.1% (3/141) in patients with AAA ≥5.6 cm (p=0.45). All-cause mortality was not significantly affected by comorbidities. However, AAA size ≥5.6 cm was associated with increased 3-year mortality risk (HR 1.59, 95% CI 1.001 to 2.52, p<0.049) but not 5-year (HR 1.44, 95% CI 0.98 to 2.10, p=0.062) or 10-year mortality (HR 1.28, 95% CI 0.91 to 1.80, p=0.149). After adjusting for comorbidities, AAA size ≥5.6 cm was no longer significantly associated with morality at any time point. Using a larger size cutoff (AAA size ≥6.0 cm) resulted in improved statistical significance in the unadjusted model. In the adjusted Cox model, AAA size ≥6.0 cm was significantly associated with increased risk of mortality at 3 years (HR 1.67, 95% CI 1.01 to 2.77, p<0.047), but not at longer time points.
Our study demonstrates that midterm survival after EVAR is significantly and independently associated with AAA size even after correcting for comorbidities. However, in the long term, preoperative AAA size is not an independent predictor of mortality.
研究腹主动脉瘤(AAA)大小对血管内动脉瘤修复(EVAR)后中期和长期生存的影响。
回顾性收集了 2003 年 1 月至 2013 年 12 月在一家机构接受 EVAR 治疗的 325 例连续完整 AAA 患者(平均年龄 69.7±8.5 岁;323 例男性)的数据。主要终点是 EVAR 后 3、5 和 10 年的死亡。使用受试者工作特征(ROC)曲线确定 AAA 大小和年龄的最佳截断点。采用时间事件分析(Kaplan-Meier 曲线和 Cox 比例风险模型)来确定 AAA 大小组之间全因死亡率结果的任何差异。Cox 模型根据年龄和其他合并症(高血压、高脂血症、冠心病、吸烟状况、症状状况和肌酐)进行调整;结果报告为风险比(HR)及其 95%置信区间(CI)。
该队列根据 ROC 分析分为两组,该分析定义了 AAA 大小的最佳截断点为 5.6cm,年龄>70 岁。EVAR 后平均随访时间为 45.5±29.2 个月。在 10 年的随访中,共有 134 名(41.2%)患者死亡。AAA<5.6cm 的患者 30 天死亡率为 1.1%(2/184),AAA≥5.6cm 的患者为 2.1%(3/141)(p=0.45)。合并症并不显著影响全因死亡率。然而,AAA 大小≥5.6cm 与 3 年死亡率风险增加相关(HR 1.59,95%CI 1.001 至 2.52,p<0.049),但与 5 年(HR 1.44,95%CI 0.98 至 2.10,p=0.062)或 10 年死亡率(HR 1.28,95%CI 0.91 至 1.80,p=0.149)无关。在调整合并症后,AAA 大小≥5.6cm 与任何时间点的死亡率均不再显著相关。使用更大的尺寸截止值(AAA 大小≥6.0cm)可在未调整模型中提高统计学意义。在调整后的 Cox 模型中,AAA 大小≥6.0cm 与 3 年死亡率风险增加显著相关(HR 1.67,95%CI 1.01 至 2.77,p<0.047),但与更长时间点无关。
本研究表明,EVAR 后中期生存与 AAA 大小显著相关,即使在纠正合并症后也是如此。然而,在长期随访中,术前 AAA 大小并不是死亡率的独立预测因素。